OverviewChartNewsTraderScreen

BVT Call 145 JNJ 21.02.2025/  DE000VG1F906  /

EUWAX
1/10/2025  8:48:42 AM Chg.-0.010 Bid12:18:19 PM Ask12:18:19 PM Underlying Strike price Expiration date Option type
0.290EUR -3.33% 0.290
Bid Size: 16,000		 0.300
Ask Size: 16,000		 Johnson and Johnson 145.00 USD 2/21/2025 Call
TeleTrader 1/2 J&J announces dividend for Q1 2025
TeleTrader 10/15/2024 J&J's Q3 sales rise by 5.2% to $22.5B
TeleTrader 10/1/2024 J&J: Over $2B to be put into new facility in North Carolina
TeleTrader 9/10/2024 D. S. Davis retires as director of Johnson & Johnson
TeleTrader 8/20/2024 Johnson & Johnson to buy V-Wave for up to $1.7B
GlobeNewswire 8/14/2024 BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS
TeleTrader 7/17/2024 J&J's Q2 sales up by 4.3% to $22.4 billion
GlobeNewswire 5/28/2024 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
TeleTrader 5/1/2024 J&J to pay $6.5 billion to settle US talc-related lawsuits
GlobeNewswire 4/17/2024 TRC Amends Its Tender Offer for Johnson & Johnson
GlobeNewswire 4/10/2024 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
TeleTrader 4/5/2024 J&J to acquire Shockwave Medical for $13.1B
TeleTrader 3/26/2024 J&J may allegedly acquire Shockwave Medical
GlobeNewswire 3/15/2024 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire 3/6/2024 Ambrx Shareholders Approve Acquisition by Johnson & Johnson
TeleTrader 1/27/2024 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 1/24/2024 J&J to pay $149.5M to settle Washington state opioid case
TeleTrader 1/23/2024 J&J to pay $700M in talc powder probe settlement
TeleTrader 1/23/2024 J&J's Q4 sales top estimates, up 7.3% to $21.4B
TeleTrader 1/23/2024 Johnson & Johnson Q4 earnings preview
TeleTrader 1/22/2024 Earnings preview: Tesla takes center stage
TeleTrader 1/8/2024 J&J to buy biotech company Ambrx for $2B
GlobeNewswire 12/4/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
GlobeNewswire 12/4/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
TeleTrader 11/7/2023 J&J to begin trials with surgical robot